In 2020，the import and export of pharmaceutical products continued a good growth trend. Imported pharmaceutical products totaled US＄40.478 billion，with a year-on-year increase of nearly 2.64%；exports totaled US＄38.110 billion，with a year-on-year increase of 16.58%，which is the best growth rate in the past five years. Exported APIs include chemical raw materials，biochemical raw materials and plant extracts，the year-on-year increase of which was 7% in 2020. The major exports are antibiotics，vitamins and amino acids. These with the advantage of fermentation technology are the major products exported by China. In 2020，leading APIs for export include heparin sodium，lysine，sodium glutamate，vitamin C，and citric acid. These commodities generally have a trend of rising prices，and are the main drive for stimulating exports. APIs are exported to more than 180 countries and regions，among which Asian countries grow rapidly. With the increasingly complex international political environment and the increasing tendency of trade protection，the resistance to the export of Chinese commodities，including pharmaceutical commodities，has increased.